These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 5613109)
41. [On the action of a new analgesic anti-inflammatory drug in some ocular diseases. Preliminary note]. Manusia M Minerva Med; 1967 Apr; 58(32):1484-6. PubMed ID: 6029514 [No Abstract] [Full Text] [Related]
42. [The importance of eye symptoms and eye conditions for the pharmacist]. Laux U Med Monatsschr Pharm; 1984 Nov; 7(11):324-8. PubMed ID: 6513861 [No Abstract] [Full Text] [Related]
44. [Irrigation system "Meturakol" in the treatment of dystrophic processes of the posterior eye segment]. Sidorenko EI; Podyninogin NV Vestn Oftalmol; 2000; 116(4):30-1. PubMed ID: 11031874 [TBL] [Abstract][Full Text] [Related]
45. [Some considerations on the pathogenesis and treatment of aging]. Ravina A Presse Med (1893); 1967 Apr; 75(17):855-6. PubMed ID: 6021370 [No Abstract] [Full Text] [Related]
46. [Indication for non-steroidal anti-inflammatory drugs in ophthalmology]. Tokuda H Ganka; 1968 Dec; 10(12):881-6. PubMed ID: 5752590 [No Abstract] [Full Text] [Related]
47. [Ascorbic acid in the treatment of eye diseases]. Mozherenkov VP; Agafonov BV Oftalmol Zh; 1980; 35(2):117-9. PubMed ID: 6995889 [No Abstract] [Full Text] [Related]
48. [Electroiontherapy in the overall treatment of eye diseases]. Katorgina OA; Fil'ts MA; Buzalo AF; Abashina NN; Fil'ts AO Oftalmol Zh; 1980; 35(5):262-5. PubMed ID: 7422210 [No Abstract] [Full Text] [Related]
49. [Experimental and clinical contribution to the intra-ocular use of liquid silicone]. Strampelli B; Restivo Manfridi ML Ann Ottalmol Clin Ocul; 1966 Jun; 92(6):415-28. PubMed ID: 5991603 [No Abstract] [Full Text] [Related]
50. [Topical drugs absorption in ocular surface diseases]. Durán de la Colina JA Arch Soc Esp Oftalmol; 2001 Aug; 76(8):457-8. PubMed ID: 11484138 [No Abstract] [Full Text] [Related]
51. [Use of immobilized collagenase-collapor in the treatment of eye diseases]. Kugleev AA; Zamyslova TI; Voevodina IA Vestn Oftalmol; 1995; 111(1):14-6. PubMed ID: 7771034 [TBL] [Abstract][Full Text] [Related]
52. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Del Amo EM; Urtti A Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911 [TBL] [Abstract][Full Text] [Related]
53. Somatostatin-related therapeutics in ophthalmology: a review. Missotten T; Baarsma GS; Kuijpers RW; van den Born LI; van der Loos T; Croxen R; Hofland LJ; van Hagen PM J Endocrinol Invest; 2005; 28(11 Suppl International):118-26. PubMed ID: 16625860 [TBL] [Abstract][Full Text] [Related]
55. [Influence of adenotonsillectomy and subsequent chemo-antibiotic treatment on the antistreptolysin titer in children with chronic tonsillar disease]. Fazi G Minerva Med; 1967 Dec; 58(97):4332-3. PubMed ID: 6082386 [No Abstract] [Full Text] [Related]
56. [Atropine in patients with eye diseases]. Xu YS Zhonghua Hu Li Za Zhi; 1984 Jun; 19(3):162-3. PubMed ID: 6568891 [No Abstract] [Full Text] [Related]
57. [Local express auto-cytokine therapy (a complex of cytokines) in the treatment of viral and nonviral eye lesions]. Kasparov AA; Kasparova EA; Pavliuk AS Vestn Oftalmol; 2004; 120(1):29-32. PubMed ID: 15017775 [TBL] [Abstract][Full Text] [Related]
58. [A therapeutic combination (antibiotic, antiinflammatory) in ophthalmology]. Lequin M; Didierlaurent A; Malterre M; Sourdille P; Michaud P J Med Lyon; 1967 Dec; 48(132):1781-90. PubMed ID: 5621999 [No Abstract] [Full Text] [Related]